Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL.
Curran KJ, Margossian SP, Kernan NA, Silverman LB, Williams DA, Shukla N, Kobos R, Forlenza CJ, Steinherz P, Prockop S, Boulad F, Spitzer B, Cancio MI, Boelens JJ, Kung AL, Khakoo Y, Szenes V, Park JH, Sauter CS, Heller G, Wang X, Senechal B, O'Reilly RJ, Riviere I, Sadelain M, Brentjens RJ.
Curran KJ, et al. Among authors: brentjens rj.
Blood. 2019 Dec 26;134(26):2361-2368. doi: 10.1182/blood.2019001641.
Blood. 2019.
PMID: 31650176
Free PMC article.
Clinical Trial.